This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
AB InBev (BUD) Q1 Earnings Miss, Sales Beat on Strong Volume
by Zacks Equity Research
AB InBev (BUD) reports strong organic sales growth and top-line beat in first-quarter 2019 on strong volume growth, global premiumization and ongoing revenue-management initiatives.
Top Ranked Income Stocks to Buy for May 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, May 6th.
Molson Coors (TAP) Stock Falls on Q1 Earnings & Sales Miss
by Zacks Equity Research
Molson Coors' (TAP) top and bottom lines miss estimates in first-quarter 2019, driven by soft volume, offset by higher pricing.
Top Ranked Income Stocks to Buy for April 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 29th
Boston Beer (SAM) Rises on Q1 Earnings Beat, Strong Shipments
by Zacks Equity Research
Boston Beer's (SAM) first-quarter earnings and sales gain from strong shipment volume and depletions growth. The company perks up shipments and depletions view for 2019.
Coca-Cola (KO) Stock Rises on Q1 Earnings and Sales Beat
by Zacks Equity Research
Coca-Cola's (KO) first-quarter earnings and sales top estimates, benefiting from organic revenue growth across all segments as well as execution of growth strategies.
ABEV vs. DVDCY: Which Stock Is the Better Value Option?
by Zacks Equity Research
ABEV vs. DVDCY: Which Stock Is the Better Value Option?
PepsiCo (PEP) Q1 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
PepsiCo's (PEP) first-quarter 2019 results gain from strong operating performance at international divisions, and North America snacks and beverage businesses. The company reiterates view for 2019.
PepsiCo Closes CytoSport Buyout, Fortifies Nutrition Portfolio
by Zacks Equity Research
PepsiCo (PEP) buys the CytoSport business from Hormel Foods for $465 million. Muscle Milk and Evolve brands are likely to enhance PepsiCo's nutrition portfolio.
Ambev (ABEV) Upgraded to Buy: Here's Why
by Zacks Equity Research
Ambev (ABEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).